These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 11274893)

  • 1. Drug-like properties and the causes of poor solubility and poor permeability.
    Lipinski CA
    J Pharmacol Toxicol Methods; 2000; 44(1):235-49. PubMed ID: 11274893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview on the Rule of Five.
    Pollastri MP
    Curr Protoc Pharmacol; 2010 Jun; Chapter 9():Unit 9.12. PubMed ID: 22294375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
    Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
    Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-like property concepts in pharmaceutical design.
    Di L; Kerns EH; Carter GT
    Curr Pharm Des; 2009; 15(19):2184-94. PubMed ID: 19601822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which in vitro screens guide the prediction of oral absorption and volume of distribution?
    van de Waterbeemd H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):162-6. PubMed ID: 15733210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting oral bioavailability enhancing formulations during drug discovery and development.
    Leucuta SE
    Expert Opin Drug Discov; 2014 Feb; 9(2):139-50. PubMed ID: 24387781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in predicting human ADME parameters in silico.
    Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
    J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.
    Wager TT; Chandrasekaran RY; Hou X; Troutman MD; Verhoest PR; Villalobos A; Will Y
    ACS Chem Neurosci; 2010 Jun; 1(6):420-34. PubMed ID: 22778836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based medicinal chemistry optimization of high-throughput screening (HTS) hits for orally active antimalarials. Part 1: challenges in potency and absorption, distribution, metabolism, excretion/pharmacokinetics (ADME/PK).
    Chatterjee AK
    J Med Chem; 2013 Oct; 56(20):7741-9. PubMed ID: 23927720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
    Bergström CA
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research.
    Varma MV; Khandavilli S; Ashokraj Y; Jain A; Dhanikula A; Sood A; Thomas NS; Pillai O; Sharma P; Gandhi R; Agrawal S; Nair V; Panchagnula R
    Curr Drug Metab; 2004 Oct; 5(5):375-88. PubMed ID: 15544432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.
    Gobeau N; Stringer R; De Buck S; Tuntland T; Faller B
    Pharm Res; 2016 Sep; 33(9):2126-39. PubMed ID: 27278908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties in pharmacokinetic lead optimization.
    Krämer SD; Wunderli-Allenspach H
    Farmaco; 2001; 56(1-2):145-8. PubMed ID: 11347958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
    Lipinski CA; Lombardo F; Dominy BW; Feeney PJ
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):3-26. PubMed ID: 11259830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico pKa prediction and ADME profiling.
    Cruciani G; Milletti F; Storchi L; Sforna G; Goracci L
    Chem Biodivers; 2009 Nov; 6(11):1812-21. PubMed ID: 19937818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.